profile

T2B Monthly

Featured Post

What Now Counts as Proof of Comms Impact?

Hi! There's usually no shortage of data we have at our disposal as communicators. But what to focus on and signals stakeholder impact is often harder to identify. At next week's Virtual Biopharma Comms Forum, our panel “Measuring What Matters to the Business” will bring together perspectives from inside and outside comms to examine what credible evidence of impact looks like now, and how expectations are changing. Joining the conversation on Oct. 6th @ 11 a.m. ET: 💬 Brindha Dyer, Executive...

Hi! A quick reminder that our Q3 Culture Connect Roundtable event is tomorrow, (Tuesday) September 29th, at 12 p.m. ET / 9 a.m. PT / 5 p.m. BST. The topic is “Building a Credible Biopharma Employer Brand Through Growth and Change.” Employer brand matters well beyond hiring. It’s shaped by how employees experience the company, how organizations communicate and behave through periods of growth and change, and whether the story being told externally matches the reality people experience...

Hi! Corporate affairs keeps getting broader, but there’s no single model for what belongs inside the function... or how much the function should directly own. On Day 2 of our upcoming Virtual Biopharma Comms Forum, we’re bringing together leaders working within very different company structures to compare how those boundaries are taking shape in practice. The New Boundaries of Corporate Affairs Panel discussion @ Virtual Biopharma Comms Forum | Wednesday, October 7th @ 2:10 p.m. ET Joining...

Hi! A quick reminder that our September Comm Convo is tomorrow, September 24th, at 12 p.m. ET / 9 a.m. PT / 5 p.m. BST. We called this session "Beyond the Binder in the Era of Constant Crisis" because so much of crisis readiness now comes down to judgment: knowing what deserves preparation, what requires an immediate response, and how to make good decisions when the facts are incomplete or still changing. What we'll get into tomorrow: Prioritizing what to prepare for based on the stage and...

Hi! When Jessica Freifeld signed on to support thought leadership and LinkedIn for Parabilis' CEO, she had no idea that she’d eventually be leading the communications effort for the largest IPO for a venture-backed biotech company. But she soon found herself working alongside not only the CEO, but also the finance team, banks, legal counsel, and agency partners to sharpen a differentiated investor narrative for the company. On Day 2 of our upcoming Virtual Biopharma Comms Forum, Jessica will...

Hi! For us at T2B and probably for most of you, too, September is not only the return from summertime, but also the turn around the corner that takes us through the end of the year and into JPM. This year feels especially jam-packed, so before anything else, I want to thank everyone who joined us at our T2Bmeets last week along the Eastern Seaboard, in D.C., Philly, and Boston for making the time — time away from work, client deadlines, family, travel, and everything else competing for it. A...

Hi! Patients and patient advocacy organizations show up across biopharma communications in all kinds of ways: sharing lived experience, reviewing materials, advising teams, participating in research, speaking at events, and helping organizations better understand the communities they serve. At our August Comm Convo, Rethinking What We Ask of Patients, we took a closer look at what makes those engagements thoughtful, useful, and sustainable. A huge thank you to Erin Murphy (Alagille Syndrome...

Hi! We communicators seek to become -- and remain -- trusted advisors to the C-suite, whether at our own organizations or at our client companies. But we don’t often hear from the executive receiving that counsel what was useful, what changed their thinking, what missed the mark, and what happened once the comms team left the room. So, for the opening session of our 2nd Annual Virtual Biopharma Comm Forum, we’re flipping the usual format to hear from a CEO. On Tuesday, October 6th, Jodie...

Hi! Depending on how you define the sector, there are thousands of biopharma companies -- and many more organizations across the broader life sciences ecosystem. That’s a lot of employers competing for increasingly specialized talent. And when so many can point to great science, meaningful work, and the opportunity to make a difference, standing out certainly isn’t easy. AI is adding another layer. Candidates can now use AI tools to research potential employers, which means their first...

Before today’s announcement, we want to acknowledge September 11th and remember those who lost their lives, their families, and all those affected. Hi! Some days it feels like we exist in a world of constant crisis. Political volatility, regulatory shifts, reputational issues, and the speed of social media rapidly turn emerging issues into acute ones for our industry. And somehow, the crises in front of us are often not the ones we planned for. This raises a new set of questions for...